AlphaYouCRMD: Dillione Janet discloses securities transactions
By AlphaYouPublished Form 4
Dillione Janet
Reporting filer
Dillione Janet reported Exercise or conversion in CorMedix Inc.: 48909 units of Common Stock, dated 2026-09-18. The full Form 4 contains 2 transaction entries.
- Disclosed
- Sep 19, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Dillione Janet | 2026-09-18 | M | Exercise or conversion | 48909 | Not stated (see footnotes) | 117,835 | 1 day | Filed terms
|
| Phantom Stock (derivative) | Dillione Janet | 2026-09-18 | M | Exercise or conversion | 48909 | Not stated (see footnotes) | 0 | 1 day | Filed terms
|
Common Stock
- Owner
- Dillione Janet
- Date
- 2026-09-18
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 48909
- Price
- Not stated (see footnotes)
- Following holdings
- 117,835
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-18
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 48909
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 117835
- direct Or Indirect Ownership: D
Phantom Stock (derivative)
- Owner
- Dillione Janet
- Date
- 2026-09-18
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 48909
- Price
- Not stated (see footnotes)
- Following holdings
- 0
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Phantom Stock
- id: F1
- transaction Date: 2026-09-18
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 48909
- id: F1
- transaction Acquired Disposed Code: D
- id: F1
- id: F1
- underlying Security Title: Common Stock
- underlying Security Shares: 48909
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Dillione Janet: Director.
- F1: Each phantom stock unit is the economic equivalent of one share of common stock. On September 17, 2025, the Company terminated the CorMedix Inc. Deferred Compensation Plan for Directors (the "Plan"). On September 18, 2026, in connection with the termination of the Plan, all of the Reporting Person's phantom stock units were settled in an equal number of shares of common stock.
Original sources
Prepared automatically from public filing data. Report a correction.